Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM0RA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,433
Award facts
- Contract value 100% obligated
- $7,432.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,432.61 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HEPLISAV-B is a recombinant hepatitis B vaccine used for immunization of adult populations, representing part of the critical medical supply needs for federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026. As a prime pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains a substantial federal contract portfolio supporting military and veteran healthcare systems, the Defense Health Agency, and the U.S. Coast Guard. The company's established capacity to fulfill vaccine procurement and specialized medical supply requirements demonstrates its critical role within the DLA Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DR26FM0RA?
SPE2DR26FM0RA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FM0RA worth?
The government has obligated $7,433 on SPE2DR26FM0RA.
Is contract SPE2DR26FM0RA an order under another contract?
Yes. SPE2DR26FM0RA is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0RA competed?
The extent of competition for SPE2DR26FM0RA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award